ELVN logo

Enliven Therapeutics, Inc. (ELVN) return on assets

Annual ROA:

-29.79%+9.56%(+24.29%)
December 31, 2024

Summary

  • As of today (August 19, 2025), ELVN annual return on assets is -29.79%, with the most recent change of +9.56% (+24.29%) on December 31, 2024.
  • During the last 3 years, ELVN annual ROA has fallen by -5.56% (-22.95%).
  • ELVN annual ROA is now -1479.17% below its all-time high of 2.16%, reached on December 1, 2017.

Performance

ELVN ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNprofitability metrics

Quarterly ROA:

-28.39%+1.18%(+3.99%)
June 30, 2025

Summary

  • As of today (August 19, 2025), ELVN quarterly return on assets is -28.39%, with the most recent change of +1.18% (+3.99%) on June 30, 2025.
  • Over the past year, ELVN quarterly ROA has dropped by -0.86% (-3.12%).
  • ELVN quarterly ROA is now -644.91% below its all-time high of 5.21%, reached on December 31, 2022.

Performance

ELVN Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNprofitability metrics

ROA Formula

ROA =  Net Income
Total Assets
✕ 100%

ELVN ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+24.3%-3.1%
3 y3 years-22.9%+47.7%
5 y5 years+74.0%-30.9%

ELVN ROA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-2154.5%+24.3%-644.9%+47.7%
5 y5-year-2154.5%+74.0%-644.9%+50.8%
alltimeall time-1479.2%+76.5%-644.9%+50.8%

ELVN ROA History

DateAnnualQuarterly
Jun 2025
-
-28.39%(-4.0%)
Mar 2025
-
-29.57%(+4.5%)
Dec 2024
-29.79%(-24.3%)
-28.30%(+1.0%)
Sep 2024
-
-28.01%(+1.7%)
Jun 2024
-
-27.53%(+2.4%)
Mar 2024
-
-26.89%(-7.7%)
Dec 2023
-39.35%(-2813.8%)
-29.12%(+195.6%)
Sep 2023
-
-9.85%(+62.0%)
Jun 2023
-
-6.08%(+268.5%)
Mar 2023
-
-1.65%(-131.7%)
Dec 2022
1.45%
5.21%(-110.0%)
Sep 2022
-
-52.25%(-3.7%)
Jun 2022
-
-54.27%(-4.9%)
DateAnnualQuarterly
Mar 2022
-
-57.05%(-1.0%)
Dec 2021
-24.23%(-63.6%)
-
Dec 2021
-
-57.65%(+7.3%)
Sep 2021
-
-53.72%(+3.6%)
Jun 2021
-
-51.87%(+15.5%)
Mar 2021
-
-44.91%(+12.0%)
Dec 2020
-66.63%(-41.8%)
-40.09%(+17.9%)
Sep 2020
-
-33.99%(+56.7%)
Jun 2020
-
-21.69%(+73.0%)
Mar 2020
-
-12.54%
Dec 2019
-114.45%(-9.5%)
-
Dec 2018
-126.47%(-5955.1%)
-
Dec 2017
2.16%
-

FAQ

  • What is Enliven Therapeutics, Inc. annual return on assets?
  • What is the all time high annual ROA for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. annual ROA year-on-year change?
  • What is Enliven Therapeutics, Inc. quarterly return on assets?
  • What is the all time high quarterly ROA for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. quarterly ROA year-on-year change?

What is Enliven Therapeutics, Inc. annual return on assets?

The current annual ROA of ELVN is -29.79%

What is the all time high annual ROA for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high annual return on assets is 2.16%

What is Enliven Therapeutics, Inc. annual ROA year-on-year change?

Over the past year, ELVN annual return on assets has changed by +9.56% (+24.29%)

What is Enliven Therapeutics, Inc. quarterly return on assets?

The current quarterly ROA of ELVN is -28.39%

What is the all time high quarterly ROA for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high quarterly return on assets is 5.21%

What is Enliven Therapeutics, Inc. quarterly ROA year-on-year change?

Over the past year, ELVN quarterly return on assets has changed by -0.86% (-3.12%)
On this page